420 related articles for article (PubMed ID: 9617345)
1. Reduced invasive and metastatic potentials of KAI1-transfected melanoma cells.
Takaoka A; Hinoda Y; Sato S; Itoh F; Adachi M; Hareyama M; Imai K
Jpn J Cancer Res; 1998 Apr; 89(4):397-404. PubMed ID: 9617345
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells.
Yang X; Wei LL; Tang C; Slack R; Mueller S; Lippman ME
Cancer Res; 2001 Jul; 61(13):5284-8. PubMed ID: 11431371
[TBL] [Abstract][Full Text] [Related]
3. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene.
Takaoka A; Hinoda Y; Satoh S; Adachi Y; Itoh F; Adachi M; Imai K
Oncogene; 1998 Mar; 16(11):1443-53. PubMed ID: 9525743
[TBL] [Abstract][Full Text] [Related]
4. Anti-cell death activity promotes pulmonary metastasis of melanoma cells.
Takaoka A; Adachi M; Okuda H; Sato S; Yawata A; Hinoda Y; Takayama S; Reed JC; Imai K
Oncogene; 1997 Jun; 14(24):2971-7. PubMed ID: 9205104
[TBL] [Abstract][Full Text] [Related]
5. Metastasis-suppressor KAI1/CD82 induces homotypic aggregation of human prostate cancer cells through Src-dependent pathway.
Jee B; Jin K; Hahn JH; Song HG; Lee H
Exp Mol Med; 2003 Feb; 35(1):30-7. PubMed ID: 12642901
[TBL] [Abstract][Full Text] [Related]
6. Effects of KAI1/CD82 on biological behavior of human colorectal carcinoma cell line.
Liu L; Wu DH; Li ZG; Yang GZ; Ding YQ
World J Gastroenterol; 2003 Jun; 9(6):1231-6. PubMed ID: 12800230
[TBL] [Abstract][Full Text] [Related]
7. KAI1 is a potential target for anti-metastasis in pancreatic cancer cells.
Xu JH; Guo XZ; Ren LN; Shao LC; Liu MP
World J Gastroenterol; 2008 Feb; 14(7):1126-32. PubMed ID: 18286698
[TBL] [Abstract][Full Text] [Related]
8. Inverse correlation between KAI1 mRNA levels and invasive behaviour in bladder cancer cell lines.
Jackson P; Kingsley EA; Russell PJ
Cancer Lett; 2000 Aug; 156(1):9-17. PubMed ID: 10840154
[TBL] [Abstract][Full Text] [Related]
9. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer.
Lee JH; Park SR; Chay KO; Seo YW; Kook H; Ahn KY; Kim YJ; Kim KK
Cancer Res; 2004 Jun; 64(12):4235-43. PubMed ID: 15205336
[TBL] [Abstract][Full Text] [Related]
10. [Effect of tumor suppressor gene KAI1 on the biological behaviors of human colorectal carcinoma].
Liu L; Li ZG; Yang GZ; Ding YQ
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jun; 23(6):587-90, 594. PubMed ID: 12810384
[TBL] [Abstract][Full Text] [Related]
11. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade.
Bouras T; Frauman AG
J Pathol; 1999 Aug; 188(4):382-8. PubMed ID: 10440748
[TBL] [Abstract][Full Text] [Related]
12. Activation of the tumor metastasis suppressor gene, KAI1, by etoposide is mediated by p53 and c-Jun genes.
Mashimo T; Bandyopadhyay S; Goodarzi G; Watabe M; Pai SK; Gross SC; Watabe K
Biochem Biophys Res Commun; 2000 Aug; 274(2):370-6. PubMed ID: 10913345
[TBL] [Abstract][Full Text] [Related]
13. Suppression of pulmonary metastasis in murine B16 melanoma cells by transfection of a sialidase cDNA.
Tokuyama S; Moriya S; Taniguchi S; Yasui A; Miyazaki J; Orikasa S; Miyagi T
Int J Cancer; 1997 Nov; 73(3):410-5. PubMed ID: 9359489
[TBL] [Abstract][Full Text] [Related]
14. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2.
Dong JT; Lamb PW; Rinker-Schaeffer CW; Vukanovic J; Ichikawa T; Isaacs JT; Barrett JC
Science; 1995 May; 268(5212):884-6. PubMed ID: 7754374
[TBL] [Abstract][Full Text] [Related]
15. Gelsolin functions as a metastasis suppressor in B16-BL6 mouse melanoma cells and requirement of the carboxyl-terminus for its effect.
Fujita H; Okada F; Hamada J; Hosokawa M; Moriuchi T; Koya RC; Kuzumaki N
Int J Cancer; 2001 Sep; 93(6):773-80. PubMed ID: 11519036
[TBL] [Abstract][Full Text] [Related]
16. Relationship between expression of KAI1 metastasis suppressor gene, mRNA levels and p53 in human bladder and prostate cancer cell lines.
Jackson P; Grimm MO; Kingsley EA; Brosius U; Antalis T; Yardley G; Russell PJ
Urol Oncol; 2002; 7(3):99-104. PubMed ID: 12474542
[TBL] [Abstract][Full Text] [Related]
17. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers.
Yu Y; Yang JL; Markovic B; Jackson P; Yardley G; Barrett J; Russell PJ
Clin Cancer Res; 1997 Jul; 3(7):1045-9. PubMed ID: 9815782
[TBL] [Abstract][Full Text] [Related]
18. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines.
Sigala S; Faraoni I; Botticini D; Paez-Pereda M; Missale C; Bonmassar E; Spano P
Clin Cancer Res; 1999 May; 5(5):1211-8. PubMed ID: 10353759
[TBL] [Abstract][Full Text] [Related]
19. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
Zhou B; Liu L; Reddivari M; Zhang XA
Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
[TBL] [Abstract][Full Text] [Related]
20. KAI1 inhibits anchorage-dependent and -independent pancreatic cancer cell growth.
Guo XZ; Xu JH; Liu MP; Kleeff J; Ho CK; Ren LN; Li HY; Köninger J; Cui ZM; Wang D; Wu CY; Zhao JJ; Friess H
Oncol Rep; 2005 Jul; 14(1):59-63. PubMed ID: 15944768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
